DOI: 10.1128/CVI.00066-10
Article Information
PubMed
Published By
History
- Received February 12, 2010
- Returned for modification March 16, 2010
- Accepted June 2, 2010
- Published online July 30, 2010.
Copyright & Usage
Copyright © 2010 American Society for Microbiology
Article Versions
- Accepted Manuscript version (June 09, 2010).
- You are viewing the most recent version of this article.
Author Information
- Shixing Tang1*,
- Jiangqin Zhao1,
- Aifeng Wang1,
- Ragupathy Viswanath1,
- Harri Harma2,
- Richard F. Little3,
- Robert Yarchoan3,
- Susan L. Stramer4,
- Phillipe N. Nyambi5,
- Sherwin Lee1,
- Owen Wood1,
- Eric Y. Wong1,
- Xue Wang1 and
- Indira K. Hewlett1*
- 1Lab of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892
- 2Laboratory of Biophysics, University of Turku, FIN-20520 Turku, Finland
- 3HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892
- 4American Red Cross, Biomedical Services Scientific Support Office, 9315 Gaither Road, Gaithersburg, Maryland 20877
- 5Pathology, New York University School of Medicine, New York, New York 10010
- ↵* Corresponding author. Mailing address: Lab of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Building 29B, Room 4NN16, 8800 Rockville Pike, Bethesda, MD 20892. Phone: (301) 827-0795. Fax: (301) 827-0998. E-mail for Shixing Tang: shixing.tang{at}fda.hhs.gov . E-mail for Indira Hewlett: indira.hewlett{at}fda.hhs.gov
† Supplemental material for this article may be found at http://cvi.asm.org/ .
‡ The authors have paid a fee to allow immediate free access to this article.
Article usage
Characterization of Immune Responses to Capsid Protein p24 of Human Immunodeficiency Virus Type 1 and Implications for Detection
